A randomized noncompartive phase II study of maintenance therapy with multiepitope vaccine Tedopi (OSE2101) +/- nivolumab or FOLFIRI after induction chemotherapy (CT) with FOLFIRINOX in patients (Pts) with advanced pancreatic ductal adenocarcinoma (aPDAC)
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | A randomized noncompartive phase II study of maintenance therapy with multiepitope vaccine Tedopi (OSE2101) +/- nivolumab or FOLFIRI after induction chemotherapy (CT) with FOLFIRINOX in patients (Pts) with advanced pancreatic ductal adenocarcinoma (aPDAC) |
| Type de publication | Journal Article |
| Year of Publication | 2019 |
| Auteurs | Neuzillet C, Hautefeuille V, Lambert A, Garcia-Larnicol M-L, Vernerey D |
| Journal | JOURNAL OF CLINICAL ONCOLOGY |
| Volume | 37 |
| Date Published | MAY 20 |
| Type of Article | Meeting Abstract |
| ISSN | 0732-183X |
| DOI | 10.1200/JCO.2019.37.15_suppl.TPS4160 |